Clinical Researchin New Orleans, LA | Audubon Dermatology

A Phase 3, Double-Blind, Randomized, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of YCANTH (VP-102) in Subjects with Common Warts (Verruca Vulgaris)

A Phase 2, Dose Ranging, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Moderate to Severe Hidradenitis Suppurativa (COMPASS 2 – HS)

A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Zasocitinib in Participants with Nonsegmental Vitiligo

A Phase 2, Randomized, Double-blind, Vehicle-Controlled, Multi-Center Clinical Trial Study to Evaluate AI-09 In Participants With Glabellar Lines

A Prospective, Open-label Study to Evaluate Subject Satisfaction with Overall Facial Appearance After Treatment with JUVÉDERM® Products in Medical Weight Loss Subjects

A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial with extension period to evaluate the efficacy and safety of Xeomin® injections for the prevention of chronic migraine

A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial with extension period to evaluate the efficacy and safety of Xeomin® injections for the prevention of episodic migraine

A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

A Phase 1/2, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy and immunogenicity of an Acne mRNA vaccine candidate in participants with mild acne

A Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria

US HARMONY in DIVERSITY: A Prospective, Open-label Study to Evaluate Subject Satisfaction with the Overall Face and Neck Appearance After Combined Treatment

A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy, and Safety Study of Povorcitinib in Participants With Chronic Spontaneous Urticaria

A Randomized, Double-Blind, Vehicle-Controlled Phase 2b Trial Evaluating the Efficacy, Safety & Pharmacokinetics of VYN201 Gel in the Treatment
of Non-Segmental Vitiligo

Selective Treatment of Oral Povorcitinib in Hidradenitis Suppurativa Long-Term Extension Study (STOP-HS LTE) A Phase 3, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

A Phase I/II, randomized, placebo-controlled, multi-arm, dose-finding study to evaluate the safety, efficacy and immunogenicity of an Acne mRNA vaccine candidate in adults with moderate to severe acne 18 to 45 years of age

BOTOX® (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

A phase 3b, interventional, adaptive clinical trial to evaluate the efficacy and safety of tralokinumab 300 mg every second week monotherapy compared with placebo in subjects with moderate to severe atopic hand eczema who are candidates for systemic therapy

A randomized, blinded evaluator, no-treatment control, multicenter, prospective, clinical study of RHA®4 for the correction of sagging jawline

A 2-part, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate-to-Severe Pruritus in Adult Subjects With Notalgia Paresthetica

A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema

A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Moderate to Severe Hidradenitis Suppurativa

A 6-Month Phase 3, Multicenter, Prospective, Randomized, Double-Blind, Vehicle-Controlled Study, to Evaluate the Efficacy and Safety of Topically Applied Clascoterone (Cortexolone 17α-Propionate) Solution for the Treatment of Androgenetic Alopecia in Males, Followed by a 6-Month Single-Blind Treatment with Clascoterone or Vehicle BID Solution (SCALP 1)

Selective Treatment of Oral Povorcitinib in Hidradenitis Suppurativa Study 2 (STOP-HS2) A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa

A Randomized, No-Treatment-Controlled, Evaluator-Blinded, Multi-Center Study To Evaluate The Effectiveness And Safety Of Restylane Contour In The Treatment Of Temple Hollowing

A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group, Multi-Dose Study To Evaluate The Efficacy And Safety Of Tdm-105795 In Male Subjects With Androgenetic Alopecia

Multicenter, Evaluator-blinded, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLITETM XC Injectable Gel for Improvement in Neck Appearance

A Phase 3 Randomized, Double-Blind, 52-Week Placebo-Controlled, Multi-Center Study Investigating The Efficacy, Safety, And Tolerability Of Ritlecitinib In Adult And Adolescent Participants With Non Segmental Vitiligo

A Phase 2, Double-Blind, Randomized, Vehicle-Controlled, Efficacy, and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa

A Multi-Center, Double-Blind, Randomized, Three-Arm, Placebo Controlled, Parallel-Design Group Study To Evaluate The Therapeutic Equivalence Comparing Trifarotene Cream, 0.005% (Teva Pharmaceuticals, Inc. To Aklief ® (Trifarotene 0.005% Cream) (Galderma Laboratories, L.P., Usa), In The Treatment Of Acne Vulgaris

A Two-Part, Multicenter, Randomized, Double- Blind Study To Evaluate The Efficacy And Safety Of Oral Difelikefalin As Adjunct Therapy To A Topical Corticosteroid For Moderate-To-Severe Pruritus In Adult Subjects With Atopic Dermatitis

A Phase 3, Multicenter, Open-Label, Single-Arm Study To Evaluate The Safety And Tolerability Of Tirbanibulin Ointment 1% Applied To A Field Of Approximately 100cm2 On The Face Or Balding Scalp In Adult Patients With Actinic Keratosis

Phase 3, Multicenter Open-Label Extension Study To Evaluate The Safety Of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex For The Treatment Of Platysma Prominence

A Phase 3, Multicenter Study To Evaluate The Safety And Efficacy Of AGN-151586 For The Treatment Of Glabellar Lines

A Phase 3, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy And Safety Study Of Ruxolitinib Cream Followed By An Open-Label Extension Period In Adults With Chronic Hand Eczema

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Platysma Prominence.

A Phase IIA, Multicenter, Double Blind, Placebo Controlled, Randomized Clinical Trial To Assess Safety, Efficacy And Pharmacokinetics Of Rifaximin Delayed-Release (Rifaximin-EIR) In Patients With Moderate-To-Severe Papulopustular Rosacea

Phase 4, Multicenter Study On The Evaluation Of Acne-Induced Hyperpigmentation During Treatment Of Acne Vulgaris Subjects With Trifarotene 50 µg/G Cream Versus Vehicle Cream Over 24 Weeks

An Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Tapinarof Cream 1% in Subjects with Atopic Dermatitis

A Phase 2, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects with Acne Vulgaris

A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Children (Ages ≥ 2 Years to < 12 Years) With Atopic Dermatitis.

A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Efficacy and Safety of AS012 in Subjects with Non-Segmental Vitiligo

A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group Study, Comparing Halobetasol Propionate And Tazarotene Topical Lotion 0.01%/0.045% (Taro Pharmaceuticals U.S.A., Inc.) To Duobrii® Lotion (Halobetasol Propionate And Tazarotene Lotion) 0.01%/0.045% (Reference Listed Drug) And Both Active Treatments To A Placebo Control In The Treatment Of Moderate To Severe Plaque Psoriasis

A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied Sofpironium Bromide Gel, 15% in Subjects with Axillary Hyperhidrosis (the “Cardigan II Study”)

A Randomized, Double-Blind, Placebo-Controlled, Parallel Study To Evaluate The Efficacy, Safety, And Tolerability Of Blu-5937 For The Treatment Of Chronic Pruritus In Adult Subjects With Atopic Dermatitis (Blueprint)

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults

Topical Berdazimer Gel, A Nitric Oxide-Releasing Macromolesule –  a phase 3 multi-center, randomized, double-blind, vehicle-controlled, parallel group study comparing the efficacy and safety of SB206 and vehicle gel applied once daily in the treatment of molluscum contagiosum

A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.3% in Subjects with Chronic Plaque Psoriasis

Topical PDE-4 Inhibitor – A phase 3, 8-week, parallel group, double blind, vehicle-controlled study of the safety and efficacy of ARQ151 Cream 0.3% administered to QD in subjects with chronic plaque psoriasis

Topical Ivermectin – a multi-center, double-blind, randomized, placebo controlled, patallel-group study, comparing 1% ivermectin cream (Taro Pharmaceuticals U.S.A. Inc.) to 1% ivermectin cream (Soolantra) and both active treatments to a placebo control in the treatment of moderate to severe facial rosacea

Poly-L-Lactic Acid Implant – a randomized, evaluator-blinded, no-treatment controlled, multi-center study to evaluate the effectiveness and safety of Sculptra Aesthetic for correction of cheek wrinkles

Topical Non-Steroid, Therapeutic AhR-Modulating Agent – a long-term, open-label extension study to evaluate the safety and efficacy of 1% tapinarof cream for the treatment of plaque psoriasis in adults

A multicenter, evaluator-blinded, randomized, parallel-group, controlled study of the safety and effectiveness of JUVÉDERM VOLUMA® XC injectable gel for correction of temple hollowing

Oral Kappa Receptor Agonist – a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral difelikefalin (CR845) for moderate to severe pruritus in adults subjects with atopic dermatitis

A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo- Controlled Study to Evaluate Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Platysmal Bands

A Prospective, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of a Combination of 3% Minocycline and 0.3% Adapalene Topical Foam Formulation for the Treatment of Moderate-to-Severe Acne (Study FX2016-40)

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Pilot Study to Investigate the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Diseases Characterized by Chronic Pruritus

Topical JAK inhibitor – a phase 3, double-blind, randomized, 8-week, vehicle-controlled efficacy and safety study of ruxolitinib cream followed by a long-term safety extension period in adolescents and adults with atopic dermatitis

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults

A Safety, Tolerability, Pharmacokinetic, and Efficacy Study of ABY-035/AFO2 Given as Multiple Oral Doses in Sequential Escalating Dose Cohorts in Psoriasis Subjects

A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients with Moderate Atopic Dermatitis

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects with Severe Chronic Hand Eczema Refractory to Topical Corticosteroid Therapy

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of BTX 1503 in Patients with Moderate to Severe Acne Vulgaris

A Multicenter, Randomized, Phase 2, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Study to Evaluate the Safety and Efficacy of Q301 Cream in Adolescents and Adults with Mild to Moderate Atopic Dermatitis

An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus

A Multi-Center, Open-Label, Long-Term Safety Study of S5G4T-1 to Evaluate the Safety of S5G4T-1 in Papulopustular Rosacea Patients

A Randomized, Evaluator-Blinded, Parallel, Comparator-Controlled Study to Evaluate the Safety and Effectiveness of GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults with Prurigo Nodularis

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of GBR 830 in Adult Subjects with Moderate to Severe Atopic Dermatitis

A randomized, subject and investigator blinded, placebo- controlled, multi-center study in parallel groups to assess the efficacy and safety of LYS006 in patients with moderate to severe inflammatory acne

A Double-Blind, Randomized, Vehicle-Controlled, Phase 2 Study to Assess the Safety and Efficacy of BPX-04 Minocycline Topical Gel in the Treatment of Inflammatory Lesions of Papulopustular Rosacea

A Multicenter, Randomized, Double-Blind, Secukinumab-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects with Moderate to Severe Chronic Plaque Psoriasis

A Multicenter, Open-Label Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects with Moderate to Severe Chronic Plaque Psoriasis

A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S5G4T-1 in the Treatment of Papulopustular Rosacea

A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study with an Initial Treatment Period Followed by a Randomized-Withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects with Moderate to Severe Chronic Plaque Psoriasis

A Phase 3b, Open-Label, Long-Term Study to Evaluate the Safety and Temporal Pattern of Response of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects with Moderate-to-Severe Plaque Psoriasis (AFFIRM Study)

A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study with Randomized Withdrawal and Retreatment to Evaluate the Efficacy and Safety of BMS-986165 in Subject with Moderate-to-Severe Plaque Psoriasis

A Randomized, Double-blind, Vehicle-Controlled, Phase IIb Study to Assess the Efficacy and Safety of Topically Applied DS107 Cream to Adults with Mild to Moderate Atopic Dermatitis

A Phase 3, Double-Blind, Vehicle-Controlled, Randomized, Parallel Group, Multicenter, Efficacy and Safety Study of KX2-391 Ointment 1% in Adult Subjects with Actinic Keratosis on the Face or Scalp

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to-Severe Acne Vulgaris

An Open-Label Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 for 40 weeks in the Treatment of Moderate to Severe Facial Papulopustular Rosacea (Study FX2016-13)

A randomized, double-blind, multi-center, parallel-group, placebo-controlled dose-ranging study to assess the efficacy and safety of nemolizumab (CD14152) in moderate-to-severe atopic dermatitis subjects with severe pruritus receiving topical corticosteroids

An Open-Label Study Assessing Long-Term Safety of Olumacostat Glasaretil Gel in Subjects with Acne Vulgaris

A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam Compared to Vehicle in the Treatment of Facial Papulopustular Rosacea

A Randomized, Double-Blind, Vehicle-Controlled, Efficacy and Safety Study of Olumacostat Glasaretil Gel in Subjects with Acne Vulgaris

A Randomized, Prospective, Multicenter, Double Blind, Parallel Assignment, Placebo Controlled Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® (Pimecrolimus) Cream, 1% in Patients with Mild to Moderate Atopic Dermatitis

A Multicenter, Double-blind, Randomized, Parallel-group, Vehicle-Controlled Study to Evaluate the Safety and Clinical Equivalence of a Generic Azelaic Acid Foam, 15% and the Reference Listed Finacea® (Azelaic acid) Foam, 15% in Patients with Moderate Facial Rosacea

A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis

A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks